** Shares in Almirall ALM.MC rise around 4%, topping the
Madrid General Index .SMSI , after the Spanish drugmaker said
its H1 net profit rose 28% to 15.4 million euros ($16.76
million) year-on-year
** "H1 profits just ahead," Jefferies says after forecasting
a profit of 11.6 million euros; consensus expected 14.7 million
euros, according to the brokerage
** Jefferies adds the sales are 1% above its estimates and
in line with consensus
** Ebglyss launch feedback will be the focus in the call,
Jefferies says, noting it is likely still too early for an
update on peak sales expectations
** Almirall also reiterates its 2024 guidance
($1 = 0.9189 euros)
(Reporting by Jakub Olesiuk)
((jakub.olesiuk@thomsonreuters.com))